Geron (GERN) Other Non Operating Income (2011 - 2026)
Geron recorded quarterly Other Non Operating Income of -$74000.0 in Q1 2026, down 124.26% quarter-over-quarter from $305000.0 in Q4 2025, and up 10.84% year-over-year from -$66760.9 in Q1 2025.
Geron's Other Non Operating Income history runs 13 years deep, the most recent figure standing at -$74000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 10.84% year-over-year to -$74000.0; the TTM figure through Mar 2026 stood at $9000.0 (up 100.52% YoY), while the FY2024 annual figure was -$1.7 million, changed N/A from the prior year.
- Other Non Operating Income came in at -$74000.0 for Q1 2026 at Geron, down from $305000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.1 million in Q2 2022 to a low of -$1.5 million in Q4 2024.
- A 5-year average of -$45823.5 and a median of -$62000.0 in 2024 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 6629.41% in 2022 and tumbled 2473.44% in 2024, its largest moves.
- Geron's Other Non Operating Income stood at $86000.0 in 2022, then fell by 25.58% to $64000.0 in 2023, then sank by 2473.44% to -$1.5 million in 2024, then soared by 120.08% to $305000.0 in 2025, then plunged by 124.26% to -$74000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$74000.0, $305000.0, and -$161000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Geron | 856,799.98 | 856,799.98 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74,000.00 |
| Dec 31, 2025 | 305,000.00 |
| Sep 30, 2025 | -161,000.00 |
| Jun 30, 2025 | -61,000.00 |
| Mar 31, 2025 | -83,000.00 |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -63,000.00 |
| Jun 30, 2024 | -63,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Sep 30, 2023 | -92,000.00 |
| Jun 30, 2023 | -11,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 86,000.00 |
| Sep 30, 2022 | -138,000.00 |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | -56,000.00 |
| Dec 31, 2021 | -6,000.00 |
| Sep 30, 2021 | -77,000.00 |
| Jun 30, 2021 | -17,000.00 |
| Mar 31, 2021 | 1.20 Mn |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 166,000.00 |
| Jun 30, 2020 | 41,000.00 |
| Mar 31, 2020 | -44,000.00 |
| Jun 30, 2019 | -30,000.00 |
| Mar 31, 2015 | 16,000.00 |
| Dec 31, 2014 | -15,000.00 |
| Sep 30, 2014 | 289,000.00 |
| Jun 30, 2014 | -147,000.00 |
| Mar 31, 2014 | 224,000.00 |
| Dec 31, 2013 | -109,000.00 |
| Sep 30, 2013 | -208,000.00 |
| Jun 30, 2013 | -24,000.00 |
| Mar 31, 2013 | 25,000.00 |
| Dec 31, 2012 | 23,000.00 |
| Sep 30, 2012 | -44,000.00 |
| Jun 30, 2012 | 8,000.00 |
| Mar 31, 2012 | 26,000.00 |
| Dec 31, 2011 | -2.23 Mn |
| Sep 30, 2011 | 291,000.00 |
| Jun 30, 2011 | 240,000.00 |
| Mar 31, 2011 | 39,000.00 |